nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg searchdiv qikanlogo popupnotification paper
2023 03 No.198 1-6+16
浅谈防晒剂胡莫柳酯的安全性评估及各国监管情况
基金项目(Foundation):
邮箱(Email): flzhang2007@163.com;duneer@163.com;
DOI: 10.20099/j.issn.1000-4475.2022.0103
中文作者单位:

中国食品药品检定研究院;

摘要(Abstract):

通过文献研究,总结国内外胡莫柳酯毒理学研究进展,分析欧盟消费者安全科学委员会(SCCS)3次对胡莫柳酯的评估差异和主要国家对胡莫柳酯的监管情况。胡莫柳酯体内试验慢性毒性和生殖毒性显示阳性,体外试验具有抗雄激素作用和孕激素受体拮抗作用。中国对其使用限值要求严于美国等国家,但与SCCS推荐限值仍有差异。胡莫柳酯作为常见防晒剂,其使用限值存在安全性风险,建议我国监管部门对其加大风险监测并开展安全性评估研究,为制定科学合理的使用限值提供依据。

关键词(KeyWords): 防晒剂;胡莫柳酯;安全性评估;法规监管
参考文献

[1]王淑荣,张巍.日光中紫外线照射与维生素D代谢的关系[J].中国儿童保健杂志,2008,16(1):72-73.

[2]王永亮.紫外线疾病的治疗和健康促进研究[J].口岸卫生控制,2004,9(1):31-33.

[3]郭芬.紫外线致皮肤光损伤皮肤癌的机制[J].饮食保健,2017,4(3):298.

[4]INTERNATIONAL AGENCY FOR RESEARCH.Radiation,a review of human carcinogens[M/OL]//IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.(2012)[2022-05-06].https://publications.iarc.fr/_publications/media/download/3045/d295876be020b721ff7209083d5782c910b2ed1e.pdf.

[5]SCHLUMPF M,COTTON B,CONSCIENCE M,et al.In vitro and in vivo estrogenicity of UV screens[J].Environmental Health Perspectives,2001,109(3):239-244.

[6]SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTSAND NON-FOOD PRODUCTS.Opinion on the evaluation of potentially estrogenic effects of UV-filters adopted by the SCCNFP during the 17th Plenary Meeting of 12 June 2001[EB/OL].(2001-06-12)[2022-05-06].https://ec.europa.eu/health/scientific_committees/consumer_safety/opinions/sccnfp_opinions_97_04/sccp_out145_en.htm.

[7]SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS(SCCP).Opinion on homosalate[EB/OL].(2007-03-21)[2022-05-11].http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_097.pdf.

[8]SCIENTIFIC COMMITTEE ON CONSUMER SAFETY(SCCS).Opinion on homosalate[EB/OL].(2021-06-24)[2022-05-11].https://ec.europa.eu/health/sites/default/files/scientific_committees/consumer_safety/docs/sccs_o_244.pdf.

[9]THE EUROPEAN CHEMICALS AGENCY.Homosalate genetic toxicity:in vitro[EB/OL].(2021-06-24)[2022-05-11].https://echa.europa.eu/el/registration-dossier/-/registereddossier/13246/7/7/2.

[10]GERBERICK G F,RYAN C A.Contact photoallergy testing of sunscreens in guinea pigs[J].Contact Dermatitis,1989,20(4):251-259.

[11]GERBERICK G F,RYAN C A.A predictive mouse ear-swelling model for investigating topical photoallergy[J].Food and Chemical Toxicology,1990,28(5):361-368.

[12]GONZáLEZ E,GONZáLEZ S.Drug photosensitivity,idiopathic photodermatoses,and sunscreens[J].Journal of the American Academy of Dermatology,1996,35(6):871-887.

[13]FISCHER T,BERGSTR?M K.Evaluation of customers'complaints about sunscreen cosmetics sold by the Swedish pharmaceutical company[J].Contact Dermatitis,1991,25(5):319-322.

[14]MENZ J,MULLER S A,CONNOLLY S M.Photopatch testing:a six-year experience[J].Journal of the American Academy of Dermatology,1988,18(5):1044-1047.

[15]RIETSCHEL R L,LEWIS C W.Contact dermatitis to homomenthyl salicylate[J].Archives of Dermatology,1978,114(3):442-443.

[16]THE EUROPEAN CHEMICALS AGENCY.Homosalate developmental toxicity/teratogenicity[EB/OL].(2021-06-24)[2022-05-11].https://echa.europa.eu/el/registration-dossier/-/registered-dossier/13246/7/9/3.

[17]SCHREURS R H,SONNEVELD E,JANSEN J H,et al.Interaction of polycyclic musks and UV filters with the estrogen receptor (ER),androgen receptor (AR),and progesterone receptor (PR) in reporter gene bioassays[J].Toxicological Sciences,2005,83(2):264-272.

[18]SCHREURS R,LANSER P,SEINEN W,et al.Estrogenic activity of UV filters determined by an in vitro reporter gene assay and an in vivo transgenic zebrafish assay[J].Archives of Toxicology,2002,76(5/6):257-261.

[19]KUNZ P Y,FENT K.Multiple hormonal activities of UV filters and comparison of in vivo and in vitro estrogenic activity of ethyl-4-aminobenzoate in fish[J].Aquatic Toxicology,2006,79(4):305-324.

[20]SCIENTIFIC COMMITTEE ON CONSUMER SAFETY.Scientific advice on the safety of Homosalate (CAS No 118-56-9,EC No 204-260-8) as a UV-filter in cosmetic products[EB/OL].(2021-12-02)[2022-05-11].https://ec.europa.eu/health/document/download/40b8ecf8-7c93-4a7b-b257-1fc16533ba31_en?filename=sccs_o_260.pdf.

[21]SCIENTIFIC COMMITTEE ON CONSUMER SAFETY.The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation 11th revision[EB/OL].(2021-12-30)[2022-05-11].https://ec.europa.eu/health/sites/default/files/scientific_committees/consumer_safety/docs/sccs_o_250.pdf.

[22]WORLD TRADE ORGANIZATION/TECHNICAL BARRIERSTO TRADE.Draft Commission Regulation (EU)…/…of XXXamending Annexes III and VI to Regulation (EC) No 1223/2009of the European Parliament and of the Council:G/TBT/N/EU/886[EB/OL].(2021-04-12)[2022-05-11].https://ec.europa.eu/growth/tools-databases/tbt/en/search/?tbtaction=search.detail&Country_ID=EU&num=886&dspLang=en&basdatedeb=&basdatefin=&baspays=EU&basnotifnum=886&basnotifnum2=&baskeywords=&bastypepays=&baskeywords=.

[23]刘小娟,张弦,周桓,等.2015-2019年防晒类化妆品中防晒剂的使用情况分析[J].广州化工,2020,48(24):78-80.

[24]CHAIYABUTR C,SUKAKUL T,KUMPANGSIN T,et al.Ultraviolet filters in sunscreens and cosmetic products:a market survey[J].Contact Dermatitis,2021,85(1):58-68.

[25]FEDERAL RESERVE SYSTEM BOARD OF GOVERNOR.Code of federal regulation Title 21 Chapter I Subchapter DPart 352-sunscreen drug products for over-the-counter human use[stayed indefinitely][EB/OL].(2004-06-04)[2022-05-11].https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-352.

[26]U.S.FOOD AND DRUG ADMINISTRATION.FDA proposed rule:sunscreen drug products for over-the-counter-human use;proposal to amend and lift stay on monograph[EB/OL].(2019-02-21)[2022-05-11].https://www.fda.gov/media/124655/download.

[27]EUROPEAN COMMISSION.Regulation (EC) No 1223/2009of the European Parliament and of the Council of 30 November2009 on cosmetic roducts[EB/OL].(2009-12-22)[2022-05-11].https://ec.europa.eu/health/sites/default/files/endocrine_disruptors/docs/cosmetic_1223_2009_regulation_en.pdf.

[28]EUROPEAN COMMISSION.List of uv filters allowed in cosmetic products[EB/OL].(2009-12-22)[2022-05-11].https://ec.europa.eu/growth/tools-databases/cosing/index.cfm?fuseaction=search.results&annex_v2=VI&search.

[29]HEALTH CANADA.Guidance document sunscreen monograph[EB/OL].(2012-11-16)[2022-05-11].https://www.canada.ca/en/health-canada/services/drugs-health-products/publicinvolvement-consultations/natural-health-products/draftguidance-document-sunscreen-monograph-consultationdocument.html#a3.2.

[30]THERAPEUTIC GOODS ADMINISTRATION,DEPARTMENT OF HEALTH AND AGED CARE,AUSTRALIAN GOVERNMENT.Australian regulatory guidelines for sunscreens(ARGS)[EB/OL].[2021-07-28][2022-05-11].https://www.tga.gov.au/resources/publication/publications/australian-regulatory-guidelines-sunscreens-args.

[31]国务院.中华人民共和国国务院令第727号《化妆品监督管理条例》[EB/OL].(2020-06-16)[2022-05-11].http://www.gov.cn/zhengce/content/2020-06/29/content_5522593.htm.

[32]国家食品药品监督管理总局.总局关于实施化妆品安全技术规范(2015年版)有关事宜的公告(2016年第108号)[EB/OL].(2016-05-26)[2022-05-11].https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/hzhpchjgg/hzhpcjdf/hanhzhpss/20210106020725619.html.

基本信息:

DOI:10.20099/j.issn.1000-4475.2022.0103

中图分类号:TQ658.24

引用信息:

[1]塔娜,钮正睿,苏哲等.浅谈防晒剂胡莫柳酯的安全性评估及各国监管情况[J].香料香精化妆品,2023,No.198(03):1-6+16.DOI:10.20099/j.issn.1000-4475.2022.0103.

基金信息:

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文